Regeneron Pharmaceuticals | REGN

Stock Price
739.95
Daily Change
1.20%
Yearly
17.39%
Q2 Forecast
704.17
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Kyowa Hakko Kirin 2,744.00 44.00 1.63% -0.07%
Astellas Pharma 2,229.00 -7.00 -0.31% 9.83%
AbbVie 136.84 3.43 2.57% -7.02%
Agenus 1.60 0.01 0.63% -4.76%
Agios Pharmaceuticals 26.05 0.34 1.32% 32.37%
Alimera Sciences 2.68 0.07 2.68% -56.42%
Alnylam Pharmaceuticals 193.67 5.00 2.65% 47.26%
Amgen 218.07 3.80 1.77% -12.23%
AstraZeneca 11,748.00 78.00 0.67% 16.64%
Biogen 300.20 -2.21 -0.73% 49.64%
Bluebird Bio 3.63 0.09 2.54% 14.87%
BioMarin Pharmaceutical 93.36 5.10 5.78% 20.48%
Bristol-Myers Squibb 65.66 0.98 1.52% -12.65%
Esperion Therapeutics 1.36 0.03 2.26% -76.67%
Gilead Sciences 77.89 1.68 2.20% 22.76%
GlaxoSmithKline 1,367.60 20.00 1.48% -19.32%
Intercept Pharmaceuticals 11.12 0.39 3.63% -32.11%
Incyte Corp 62.54 1.03 1.67% -15.44%
Ionis Pharmaceuticals 41.75 -1.19 -2.77% 15.49%
J&J 156.97 2.43 1.57% -11.02%
Eli Lilly 442.22 5.84 1.34% 46.60%
Merck & Co 112.52 1.59 1.43% 25.15%
Moderna 130.51 1.99 1.55% -4.84%
Neurocrine Biosciences 92.32 1.13 1.24% -3.37%
Novartis 89.37 1.31 1.49% 4.12%
Novartis 98.91 1.80 1.85% 10.99%
Iveric bio Inc. 38.03 0.24 0.64% 253.44%
Opthea 0.61 0.01 0.83% -55.19%
Puma Biotechnology 3.55 0.11 3.20% 51.71%
Pfizer 38.36 0.34 0.89% -27.89%
Ultragenyx Pharmaceutical 50.85 1.24 2.50% -1.09%
Regeneron Pharmaceuticals 739.95 8.78 1.20% 17.39%
Roche Holding 292.80 3.05 1.05% -8.70%
Seattle Genetics 195.38 0.71 0.36% 39.62%
Sanofi 51.01 0.55 1.09% -4.71%
Sarepta Therapeutics 125.16 0.88 0.71% 71.50%
Teva Pharmaceutical Industries 2,743.00 63.00 2.35% -12.78%
United Therapeutics 217.22 3.74 1.75% -4.99%
Vertex Pharmaceuticals 333.78 10.16 3.14% 23.88%

Indexes Price Day Year
US500 4282 61.35 1.45% 4.23%
USND 13241 139.78 1.07% 10.22%
USNDX 14547 105.13 0.73% 15.93%

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals traded at $739.95 this Friday June 2nd, increasing $8.78 or 1.20 percent since the previous trading session. Looking back, over the last four weeks, Regeneron Pharmaceuticals gained 7.87 percent. Over the last 12 months, its price rose by 17.39 percent. Looking ahead, we forecast Regeneron Pharmaceuticals to be priced at 704.17 by the end of this quarter and at 645.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.